RU2009149682A - Применение синтезированных в плазме полимеров, являющихся производными пиррола для нейропротекции и восстановления соединения в центральной нервной системе - Google Patents
Применение синтезированных в плазме полимеров, являющихся производными пиррола для нейропротекции и восстановления соединения в центральной нервной системе Download PDFInfo
- Publication number
- RU2009149682A RU2009149682A RU2009149682/14A RU2009149682A RU2009149682A RU 2009149682 A RU2009149682 A RU 2009149682A RU 2009149682/14 A RU2009149682/14 A RU 2009149682/14A RU 2009149682 A RU2009149682 A RU 2009149682A RU 2009149682 A RU2009149682 A RU 2009149682A
- Authority
- RU
- Russia
- Prior art keywords
- restoration
- plasma
- neuroprotection
- compound
- polymers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G61/00—Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
- C08G61/12—Macromolecular compounds containing atoms other than carbon in the main chain of the macromolecule
- C08G61/122—Macromolecular compounds containing atoms other than carbon in the main chain of the macromolecule derived from five- or six-membered heterocyclic compounds, other than imides
- C08G61/123—Macromolecular compounds containing atoms other than carbon in the main chain of the macromolecule derived from five- or six-membered heterocyclic compounds, other than imides derived from five-membered heterocyclic compounds
- C08G61/124—Macromolecular compounds containing atoms other than carbon in the main chain of the macromolecule derived from five- or six-membered heterocyclic compounds, other than imides derived from five-membered heterocyclic compounds with a five-membered ring containing one nitrogen atom in the ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/0605—Polycondensates containing five-membered rings, not condensed with other rings, with nitrogen atoms as the only ring hetero atoms
- C08G73/0611—Polycondensates containing five-membered rings, not condensed with other rings, with nitrogen atoms as the only ring hetero atoms with only one nitrogen atom in the ring, e.g. polypyrroles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/32—Materials or treatment for tissue regeneration for nerve reconstruction
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2261/00—Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
- C08G2261/30—Monomer units or repeat units incorporating structural elements in the main chain
- C08G2261/32—Monomer units or repeat units incorporating structural elements in the main chain incorporating heteroaromatic structural elements in the main chain
- C08G2261/322—Monomer units or repeat units incorporating structural elements in the main chain incorporating heteroaromatic structural elements in the main chain non-condensed
- C08G2261/3221—Monomer units or repeat units incorporating structural elements in the main chain incorporating heteroaromatic structural elements in the main chain non-condensed containing one or more nitrogen atoms as the only heteroatom, e.g. pyrrole, pyridine or triazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
- Prostheses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1. Применение синтезированных в плазме полимеров и сополимеров, являющихся производными пиррола, с легированием или без него в любом массовом количестве, форме или конфигурации, для производства имплантатов, способствующих нейропротекции и восстановлению соединения в спинном мозге после повреждения. ! 2. Способ синтеза сополимера полипиррола и полиэтиленгликоля в плазме для производства имплантатов, способствующих нейропротекции и восстановлению соединения в спинном мозге после повреждения. ! 3. Применение любого химического производного полимеров по пп.1 и 2 для увеличения биосовместимости любого устройства, используемого в качестве временного или постоянного имплантата в человеческом теле. ! 4. Применение любого химического производного полимеров по пп.1 и 2 для увеличения биосовместимости любого устройства, используемого для доставки лекарственных средств в человеческое тело. ! 5. Применение полимеров по предыдущим пунктам, где введение может осуществляться в любое время после повреждения.
Claims (5)
1. Применение синтезированных в плазме полимеров и сополимеров, являющихся производными пиррола, с легированием или без него в любом массовом количестве, форме или конфигурации, для производства имплантатов, способствующих нейропротекции и восстановлению соединения в спинном мозге после повреждения.
2. Способ синтеза сополимера полипиррола и полиэтиленгликоля в плазме для производства имплантатов, способствующих нейропротекции и восстановлению соединения в спинном мозге после повреждения.
3. Применение любого химического производного полимеров по пп.1 и 2 для увеличения биосовместимости любого устройства, используемого в качестве временного или постоянного имплантата в человеческом теле.
4. Применение любого химического производного полимеров по пп.1 и 2 для увеличения биосовместимости любого устройства, используемого для доставки лекарственных средств в человеческое тело.
5. Применение полимеров по предыдущим пунктам, где введение может осуществляться в любое время после повреждения.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/MX2007/000067 WO2008147166A1 (es) | 2007-06-01 | 2007-06-01 | Uso de polímeros derivados del pirrol sintetizados por plasma para la neuroprotección y la reconexión del sistema nervioso central |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2009149682A true RU2009149682A (ru) | 2011-07-20 |
RU2471437C2 RU2471437C2 (ru) | 2013-01-10 |
Family
ID=40075299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2009149682/14A RU2471437C2 (ru) | 2007-06-01 | 2007-06-01 | Применение синтезированных в плазме полимеров, являющихся производными пиррола для нейропротекции и восстановления соединения в центральной нервной системе |
Country Status (6)
Country | Link |
---|---|
US (1) | US8563626B2 (ru) |
EP (1) | EP2164078B1 (ru) |
JP (1) | JP5587177B2 (ru) |
CN (1) | CN101821814B (ru) |
RU (1) | RU2471437C2 (ru) |
WO (1) | WO2008147166A1 (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10597636B2 (en) | 2014-09-19 | 2020-03-24 | University Of Florida Research Foundation, Inc. | Electroactive polymeric scaffolds and method for delivering nerve growth factor to nerve tissue |
US20180214476A1 (en) * | 2017-02-01 | 2018-08-02 | North Carolina State University | Thrombin-responsive hydrogels and devices for auto-anticoagulant regulation |
KR101989468B1 (ko) * | 2017-06-22 | 2019-06-14 | 성균관대학교 산학협력단 | 줄기세포 배양용 기판의 제조방법 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4839322A (en) * | 1986-05-05 | 1989-06-13 | The Lubrizol Corporation | High surface area polymers of pyrrole or copolymers of pyrrole |
US6095148A (en) * | 1995-11-03 | 2000-08-01 | Children's Medical Center Corporation | Neuronal stimulation using electrically conducting polymers |
AU751861B2 (en) * | 1998-02-23 | 2002-08-29 | Massachusetts Institute Of Technology | Biodegradable shape memory polymers |
AU2002258637A1 (en) * | 2001-03-27 | 2002-10-08 | Board Of Regents The University Of Texas System | Biodegradable, electrically conductiong polymer for tissue engineering applications |
US7291693B2 (en) * | 2001-06-25 | 2007-11-06 | Massachusetts Institute Of Technology | Bioerodible conducting materials |
JP4738352B2 (ja) * | 2004-02-09 | 2011-08-03 | アミュレット ファーマシューティカルズ インコーポレイティッド | 一酸化窒素放出ポリマー |
-
2007
- 2007-06-01 JP JP2010510237A patent/JP5587177B2/ja active Active
- 2007-06-01 RU RU2009149682/14A patent/RU2471437C2/ru active
- 2007-06-01 US US12/602,613 patent/US8563626B2/en active Active
- 2007-06-01 EP EP07747213.2A patent/EP2164078B1/en active Active
- 2007-06-01 WO PCT/MX2007/000067 patent/WO2008147166A1/es active Application Filing
- 2007-06-01 CN CN200780100078.9A patent/CN101821814B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
US20100234488A1 (en) | 2010-09-16 |
CN101821814B (zh) | 2015-07-01 |
US8563626B2 (en) | 2013-10-22 |
WO2008147166A1 (es) | 2008-12-04 |
JP5587177B2 (ja) | 2014-09-10 |
CN101821814A (zh) | 2010-09-01 |
JP2010531674A (ja) | 2010-09-30 |
EP2164078B1 (en) | 2013-11-20 |
RU2471437C2 (ru) | 2013-01-10 |
EP2164078A1 (en) | 2010-03-17 |
EP2164078A4 (en) | 2012-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3949969A3 (en) | Benzazepine compounds, conjugates, and uses thereof | |
WO2009005909A3 (en) | Biodegradable triblock copolymers for implantable devices | |
EA201201570A1 (ru) | Способы приготовления инъекционных композиций пролонгированного действия | |
EP2309989A4 (en) | Polymerized Nanoparticles and Methods for Making and Using Them | |
MX2007012157A (es) | Micelas polimericas para suministro de farmacos. | |
WO2012018446A3 (en) | Anchor delivery system | |
WO2010005725A3 (en) | Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same | |
TW200716628A (en) | Novel compounds | |
MX366832B (es) | Composiciones de farmaco de liberacion sostenida convenientemente implantables. | |
EP1988910A4 (en) | CONJUGATES OF POLYMERS CONTAINING ACRYLOYLOXYETHYLPHOSPHORYLCHOLINE AND THEIR PREPARATION | |
DK1786400T3 (da) | Farmaceutiske sammensætning til tilförsel med kontrolleret frigivelse af biologisk aktive forbindelser | |
EA201290497A1 (ru) | Терапевтические полимерные наночастицы, включающие кортикостероиды, и способы получения таковых | |
WO2009141823A3 (en) | Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases | |
WO2005081742A3 (en) | Testosterone oral dosage formulations and associated methods | |
EP3626253A3 (en) | Stable formulations of linaclotide | |
CY1117237T1 (el) | Συνθεσεις σταθερων τιακουμυκινων | |
MX344831B (es) | Composiciones para el transplante floral fecal y metodos para elaborar y utilzar las mismas y dispositivos para suministrar las mismas. | |
WO2009135190A3 (en) | Therapeutic calcium phosphate particles and methods of making and using same | |
EP3281956A3 (en) | Human antibody drug conjugates against tissue factor | |
WO2011057225A3 (en) | Self-assembled particles from zwitterionic polymers and related methods | |
WO2012075147A3 (en) | Stable helical ionic polypeptides | |
WO2007024481A3 (en) | 4-aza-caprolactone-based polymeric compositions useful for the manufacture of biodegradable medical devices and as medical device coatings | |
WO2006081517A3 (en) | Embolization using poly-4-hydroxybutyrate particles | |
CY1109962T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας | |
ATE460396T1 (de) | N-carbamoylmethyl-4-(r)-phenyl-2-pyrrolidinon, verfahren zu dessen herstellung und pharmazeutische verwendung |